This week on Contemporary OB/GYN®: Jan. 17 to Jan. 21
Here's what's coming to Contemporary OB/GYN® this week.
The need for a universal endometriosis classification
A literature search revealed there is no international agreement on how to characterize or classify endometriosis.
Read now
Treating recurrent vulvovaginal candidiasis with honey
Because the mechanism of action of medical-grade honey (MGH) is based on enhancing wound healing and exerting strong broad-spectrum antimicrobial activity, MGH may also help to treat recurrent vulvovaginal candidiasis (RVVC), according to a review in the Journal of Fungi.
Microbial interplay of recurrent vulvovaginal candidiasis pathobiology
A clinical study has confirmed that the pathophysiology of recurrent vulvovaginal candidiasis (RVVC) relies primarily on Candida albicans (C. albicans)-specific attributes like hyphal morphogenesis, biofilm formation and pathogenesis that differentiate it from other prominent non-albicans C. (NAC) species.
Patient perspectives on vulvovaginal candidiasis
Among women with vulvovaginal candidiasis (VVC) or recurrent VVC (RVVC), the three 3 most common signs and /symptoms are itching (91.2%), burning (68.3%), and redness (58.1%), according to an online patient survey in BMC Womens Health.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
